BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 16608370)

  • 1. Systemic and localized scleroderma in children: current and future treatment options.
    Rosenkranz ME; Agle LM; Efthimiou P; Lehman TJ
    Paediatr Drugs; 2006; 8(2):85-97. PubMed ID: 16608370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scleroderma in children: emerging management issues.
    Panda S
    Indian J Dermatol Venereol Leprol; 2010; 76(4):348-56. PubMed ID: 20657114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile Scleroderma-What has Changed in the Meantime?
    Adrovic A; Sahin S; Barut K; Kasapcopur O
    Curr Rheumatol Rev; 2018; 14(3):219-225. PubMed ID: 29692255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic sclerosis (scleroderma) without scleroderma].
    Nadashkevych ON
    Lik Sprava; 2001; (3):93-4. PubMed ID: 11560041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scleroderma in children.
    Zulian F
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):576-595. PubMed ID: 29773274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scleroderma in Children and Adolescents: Localized Scleroderma and Systemic Sclerosis.
    Li SC
    Pediatr Clin North Am; 2018 Aug; 65(4):757-781. PubMed ID: 30031497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized scleroderma: clinical spectrum and therapeutic update.
    Careta MF; Romiti R
    An Bras Dermatol; 2015; 90(1):62-73. PubMed ID: 25672301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ichthyotic-appearing skin changes associated with childhood morphea, systemic sclerosis, and systemic lupus erythematosus/scleroderma overlap.
    Williams CM; Storm CA; Burns C; Rigby W; Dinulos JG
    Pediatr Dermatol; 2010; 27(2):170-3. PubMed ID: 20537069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New developments in juvenile systemic and localized scleroderma.
    Foeldvari I
    Rheum Dis Clin North Am; 2013 Nov; 39(4):905-20. PubMed ID: 24182860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and future direction in the management of scleroderma.
    Brady SM; Shapiro L; Mousa SA
    Arch Dermatol Res; 2016 Sep; 308(7):461-71. PubMed ID: 27139430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palindromic morphea: multiple recurrence of morphea lesions in a case of systemic sclerosis.
    Mizutani H; Tanaka H; Okada H; Mizutani T; Shimizu M
    J Dermatol; 1992 May; 19(5):298-301. PubMed ID: 1644954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Juvenile scleroderma].
    de Mâcedo PA; Shinjo SK; Goldenstein-Schainberg C
    Acta Reumatol Port; 2008; 33(3):289-97. PubMed ID: 18846006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic sclerosis--clinical course and treatment possibilities].
    Szymańska E; Maj M; Rudnicka L
    Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Treatment Options in Scleroderma: Recommendations and Comprehensive Review.
    Zhao M; Wu J; Wu H; Sawalha AH; Lu Q
    Clin Rev Allergy Immunol; 2022 Apr; 62(2):273-291. PubMed ID: 33449302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid for treatment of systemic sclerosis and morphea: A literature review.
    Thomas RM; Worswick S; Aleshin M
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 28032675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peristomal morphoea in a patient with systemic sclerosis.
    Jiang KW; Zagarella SS; Chan L; Harris A
    Australas J Dermatol; 2020 Nov; 61(4):e451-e452. PubMed ID: 32567671
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous and subcutaneous inflammatory sclerosis syndromes.
    Doyle JA; Connolly SM; Winkelmann RK
    Arch Dermatol; 1982 Nov; 118(11):886-90. PubMed ID: 7138043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic sclerosis and localized scleroderma in childhood.
    Zulian F
    Rheum Dis Clin North Am; 2008 Feb; 34(1):239-55; ix. PubMed ID: 18329543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capillary abnormalities, Raynaud's phenomenon, and systemic sclerosis in patients with localized scleroderma.
    Maricq HR
    Arch Dermatol; 1992 May; 128(5):630-2. PubMed ID: 1575525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentations and treatment of childhood scleroderma: localized scleroderma, eosinophilic fasciitis, systemic sclerosis, and graft-versus-host disease.
    Hedrich CM; Fiebig B; Hahn G; Suttorp M; Gahr M
    Clin Pediatr (Phila); 2011 Jul; 50(7):604-14. PubMed ID: 21525084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.